Off-Label Use of Phosphodiesterase Type 5 Inhibitor Erectile Dysfunction Medication to Enhance Sex Among Gay and Bisexual Men in Australia: Results from the FLUX Study by Hammoud, Mohamed A. et al.
Off-label use of erectile dysfunction medication to enhance sex among gay and bisexual 
men in Australia: Data from the Flux study 
Mohamed A. Hammoud, BPsy (Hons) a (mhammoud@kirby.unsw.edu.au) 
Fengyi Jin, PhD a (jjin@kirby.unsw.edu.au) 
Toby Lea, PhD b (toby.lea@unsw.edu.au) 
Lisa Maher, PhD a (lmaher@kirby.unsw.edu.au) 
Jeffrey Grierson, PhD c (jeffrey.grierson@anglia.ac.uk) 
Garrett Prestage, PhD a (gprestage@kirby.unsw.edu.au) 
a The Kirby Institute,  UNSW Australia. Level 6, Wallace Wurth Building, UNSW Australia, 
Kensington NSW 2052 Australia 
b Centre for Social Research in Health, UNSW Australia, Kensington NSW 2052 
c Anglia Ruskin University, Cambridge Campus, Cambridge CB1 1PT, United Kingdom 
 
Author Agreement/Declaration  
All authors certify that they have seen and approved the final version of the manuscript being 
submitted. All authors warrant that the article is the authors' original work, hasn't received 
prior publication and isn't under consideration for publication elsewhere. 
Conflict of interest 
All authors certify that they do not have actual or potential conflict of interest including any 
financial, personal, or other relationships with other people or organizations within three 
years of beginning the submitted world that could inappropriately influence, or be perceived 
to influence, their work.   
Off-label use of erectile dysfunction medication to enhance sex among gay and bisexual 
men in Australia: Data from the Flux study 
Abstract 
Introduction: Gay and bisexual men (GBM) use erectile dysfunction medications (EDM) 
such as Viagra™, Cialis™ and Levitra™ often with little evidence of medical indication that 
might necessitate their use. 
Aim: We investigate the prevalence and contexts of, and motivations for, EDM use, and its 
relationship to sexual risk behavior. 
Method: Between September 2014 and July 2015, Australian GBM were invited to enroll 
online through social networking and gay community sites to complete a comprehensive 
survey looking at licit and illicit drug use and their associated behaviors. A total of 2250 
GBM completed the questionnaire. 
Main outcome measures: Any EDM use, and at least weekly use in the previous six months. 
Results: Two thirds (67.7%) reported no history of EDM use in their lifetime. Approximately 
one in ten participants (11.1%) had last used EDM more than six months ago. In the previous 
six months, 11.5% reported using EDM less than monthly, 5.3% at least monthly, and 4.5% 
weekly or more often. Among men who had used EDM in the previous six months, the most 
common reasons cited for its use were: to maintain an erection for longer (73.3%), to make it 
easier to get hard (67.3%), and difficulty in attaining or maintain an erection (53.5%). 
Conclusion: While some GBM use EDM specifically for erectile dysfunction, many also use 
EDM to enhance their sexual experiences. Often, this occurs in the context of intensive sex 
partying, which may include risky sexual behavior. The use of EDM in the context of 
intensive sex partying (which include the combined use of EDM and illicit drugs), with the 
associated potential for increased risk of HIV transmission, indicates a need to consider the 
use of EDM among GBM in HIV prevention 
Key words: Viagra, Cialis, Levitra, Erectile dysfunction medication, Off-label use, Gay and 
bisexual men, Intensive sex partying, HIV risk behaviors and transmission.  
Introduction 
Gay and bisexual men (GBM) use erectile dysfunction medications (EDM) such as Viagra™, 
Cialis™ and Levitra™ often with little evidence of medical indication that might necessitate 
their use [1-5]. EDM were developed to treat medically diagnosed erectile dysfunction [6], 
which currently affects more than 150 million men worldwide [7]. Despite this, EDM have 
also been used recreationally particularly among GBM [4, 5, 8]. Off-label use of EDM are 
sometimes used to counter the effects of other illicit recreational drugs [9] and/or to enhance 
sexual experiences among GBM [4, 10]. EDM use, particularly combined with illicit drug use 
(such as amyl nitrite, gamma hydroxybutyrate (GHB) and crystalline methamphetamine) 
have been implicated in the transmission of sexually transmissible infections (STI), including 
HIV, due to higher levels of sexual risk behaviors [2, 11-14]. 
Intensive sex partying has been described as a combination of several factors that are 
associated with the risk of HIV infection [15]. These include: being very sexually active; 
being closely involved in gay community social and sexual networks; engaging in group sex; 
engaging in CLAI; and using party drugs [15]. EDM use for intensive sex partying has been 
associated with sexual risk behaviors [3, 4], such as increased numbers sex partners [2] and 
condomless anal intercourse (CLAI)[14]. GBM’s sexual practices are influenced by shared 
understandings of HIV risk and gay community norms [16]. This may also be true of drug-
use behaviors – namely off-label use of EDM.  
Despite its role in HIV risk behaviors and transmission, few studies have described the 
characteristics of GBM who use EDM, the frequency of their use, and their motivations for 
using EDM. In this paper, we use baseline data from a cohort of Australian GBM to 
investigate the prevalence and contexts of, and motivations for, EDM use, and its relationship 
to sexual risk behavior. 
Methods 
Procedures 
The Following Lives Undergoing Change (Flux) Study is an online prospective observational 
study of Australian GBM. The methods are described in greater detail elsewhere [17]. In 
brief, participants were recruited between August 2014 and July 2015 via gay community 
websites and online media, Facebook, mobile phone applications, and gay sexual networking 
websites. Ethical approval was provided by the Human Research Ethics Committee of 
UNSW Australia. 
Measures 
The online baseline questionnaire included: demographic items, questions on sexual identity, 
HIV testing history and self-reported serostatus, sexual behavior with men, and attitudes and 
beliefs about drug use. Men described their lifetime and recent (i.e. previous six months) use 
of licit and illicit drugs, as well as the frequency and methods of use of EDM in the previous 
six months. They were also asked about the reasons for their use of EDM, including whether 
they used it to ‘enhance sex’. We also included measures of social engagement with gay men 
[18] and of sexual sensation-seeking [19]. The generalized anxiety disorder assessment 
(GAD7) [20], and the patient health questionnaire (PHQ9)[21] were also included. To 
address intensive sex partying [15], we included questions about group sex, using drugs for 
sex or to enhance sex (‘party and play’ or ‘chemsex’). 
Participants and sample 
Men who lived in Australia, aged sixteen years and six months or above, were eligible for 
participation if they identified as gay or bisexual or had sex with another man in the previous 
year. Overall, 4,306 people clicked on the study website, and 2,943 completed the online 
consent form; 2,250 completed the minimum data requirements for the online questionnaire.  
Analysis 
Descriptive statistics were used to characterize the types of men who used EDM. For 
univariate analyses of whether they had used EDM in the previous six months, and, 
separately, of whether they had used EDM at least weekly, we included: age, education, 
cultural background, social engagement with gay men, sexual identification, relationship 
status, HIV status, and sexual risk behavior. Categorical variables were analyzed using 
Pearson’s chi-square test and t-tests were used for continuous variables. We used Type I error 
of 5% for these analyses. To estimate statistical associations, we used logistic regression 
models and presented Adjusted Odds Ratios (aOR) and 95% Confidence Intervals (CI). 
Associations with a p-value of less than 0.10 in univariate analyses were included in the 
multivariate analyses. Data were analyzed using SPSSTM version 23 software. 
Results 
Characteristics of the sample 
The mean age of the 2,250 men was 33.0 years (SD 12.7). Over half of participants (52.4%) 
were university educated. Almost half were in managerial (15.5%) or professional (26.8%) 
employment (Table 1). Participants predominantly identified as gay or homosexual (88.4%), 
8.8% identified as bisexual and 2.7% identified as either heterosexual or other. Most 
participants were of Anglo-Celtic background (72.0%). Most men had been tested for HIV 
(80.3%) with 7.6% reporting that they were HIV-positive. Half (50.4%) indicated they were 
in a relationship with another man, 25.9% reported that most of their friends were gay men 
and 18.4% spent much of their free time with gay friends. 
TABLE 1 
About a quarter (26.2%) of men reported having more than ten male sex partners in the 
previous six months (Table 2). One third (35.4%) had had sex with a ‘fuckbuddy’, over half 
with a casual partner (59.5), and 33.4% with a ‘boyfriend’. About a quarter reported CLAI 
with their boyfriend, and about one in twenty reported CLAI with any fuckbuddies or with 
any casual partners.  
TABLE 2 
Prevalence 
Two thirds (67.7%) reported no history of EDM use in their lifetime. Approximately one in 
ten participants (11.1%) had last used EDM more than six months ago. In the previous six 
months, 11.5% reported using EDM less than monthly, 5.3% at least monthly, and 4.5% 
weekly or more often (Table 1). Of those who used EDM in the previous six months, the 
types were: sildenafil citrate (88.3%); tadalafil (76.2%); and vardenafil (19.0%). The majority 
(55.0%) reported obtaining the medication other than by a prescription from a doctor, with 
the most common method being online procurement (33.8%), followed by a casual male sex 
partner (17.9%) and a regular fuckbuddy (15.6%). 
The majority (68.8%) reported having used illicit drugs in the previous six months, with amyl 
nitrite (52.9%), cannabis (35.4%), and crystalline methamphetamine (32.4%) being the most 
common drugs reported (Table 2). Among those who used illicit drugs, 55.6% reported 
having used ‘party drugs to enhance their sexual experiences’.  
Univariate associations  
Those who were older used EDM more recently (p<0.001) and more often (p<0.001; Table 
1). Men who ever used EDM had higher levels of education. Approximately one in five men 
who had used EDM were HIV-positive. HIV-positive men were more likely to have ever 
used EDM (p<0.001), whereas untested men were less likely to have ever used EDM 
(p<0.001). Most (82.2%) of those who used EDM in the previous six months reported having 
at least some friends who also used EDM, while 76.9% of the men who never used EDM 
reported also having no friends who used EDM. Men who had recently used EDM were more 
socially engaged with other gay men (p=0.013) and they also had higher scores on the 
measure of sexual sensation seeking (p=0.022). 
The more recently, and more frequently, men used EDM the greater the number of sexual 
partners they were likely to report in the previous six months, and the more likely they were 
to have had sex both with fuckbuddies and with casual partners (Table 2). More recent and 
frequent EDM users were also more likely to report CLAI with these partner types; nearly 
half (42.6%) of men who used EDM weekly reported CLAI with fuckbuddies, and half 
(56.4%) reported CLAI with casual partners. The more recently, and more frequently, men 
used EDM, the more likely they were to report having engaged in group sex in the previous 
six months.  
Those who used EDM more frequently were significantly more likely to use most illicit drugs 
compared to those who used EDM less frequently or did not use EDM (Table 2). Those who 
had used illicit drugs to enhance sexual pleasure were more likely to report recent EDM use 
than were those who had not used them for this purpose. 
Reasons for use 
Among men who had used EDM in the previous six months, the most common reasons cited 
for its use were: to maintain an erection for longer (73.3%), to make it easier to get hard 
(67.3%), and difficulty in attaining or maintain an erection (53.5%; Table 3).  GBM who used 
EDM weekly or more often were more likely to cite the need to maintain an erection for 
longer and to make it easier to get hard as reasons for its use. Those who used EDM monthly 
or less frequently in the previous six months were likely to cite 'fun' and the need to counter 
the effects of other drugs as reasons for its use.  
TABLE 3 
Covariates of EDM use in the previous six months 
In univariate analyses, GBM who were older, of Anglo-Celtic background, had higher 
education, were not in a relationship, were HIV-positive, and were more socially engaged 
with gay men, were significantly more likely to have used EDM in the previous six months 
(Table 4). EDM use in the previous six months was also associated with lower scores on the 
PHQ9 and GAD scales, higher scores on the sexual sensation seeking scale, having more sex 
partners, having group sex, reporting CLAI with casual partners and fuckbuddies, and using 
‘party drugs’ to enhance sex.  
In the multivariate analysis, being older, being HIV positive, being more socially engaged 
with gay men, scoring higher on the sexual sensation seeking scale, having engaged in group 
sex, engaging in CLAI with fuckbuddies, and using drugs to enhance sex were independently 
associated with EDM use in the previous six months (Table 4). 
Covariates of weekly or more frequent EDM use  
In univariate analyses, GBM who were older, of Anglo-Celtic background, and were not in a 
relationship were significantly more likely to have used EDM weekly compared to those who 
used less frequently in the previous six months (Table 4). Weekly or more frequent use of 
EDM was also associated with CLAI with casual partners and using drugs to enhance sex.  
In a multivariate analysis, being older, higher education, and having engaged in CLAI with 
casual partners were independently associated with weekly EDM use in the previous six 
months (Table 4).  
TABLE 4 
Concurrent polydrug use with EDM 
In a separate multivariate analysis looking only at concurrent polydrug use with EDM, any 
use of EDM in the previous six months was independently associated with use of amyl nitrite 
(aOR=2.58; 95%=2.01 – 3.30; p<0.001), GHB (aOR=3.36; 95%=2.19 – 5.12; p<0.001), and 
crystalline methamphetamine (aOR=3.52; 95%=2.51 – 4.92; p<0.001). 
Discussion 
The majority of men in the Flux study had never used EDM. Men who used EDM more 
recently and more frequently tended to be somewhat older. The age distribution of EDM was 
similar to what has been found elsewhere in that older men were more likely to use EDM, 
and to use it more frequently [12].Those who used EDM recently were significantly more 
likely than non-users to socialize with friends who also used EDM.  
Although EDM use is intended to treat erectile dysfunction, many men also use EDM without 
having such a medical condition [1-5]. Nonetheless, it is likely that those who do experience 
erectile dysfunction would tend to use EDM on a regular basis. The age distribution of EDM 
was similar to what has been found elsewhere in that older men were more likely to use 
EDM, and to use it more frequently [12]. The reasons men gave for their use of EDM appear 
to support this. While both weekly and less frequent users of EDM cited ‘maintaining an 
erection’ and ‘make it easier to get hard’ as reasons for their EDM use, those who used EDM 
at least weekly cited ‘difficulty in attaining or maintaining an erection’ as a reason for their 
EDM use. 
In this sample, EDM appeared to be used primarily to enhance aspects of intensive sex 
partying, for such purposes as: To maintain an erection for longer and to counter the effects 
of other drugs on the ability to attain and maintain an erection. Users of EDM were also more 
likely to engage in those practices that have been described as aspects of intensive sex 
partying. Our data support previous contention that in the context of intensive sex partying, 
GBM often use EDM, both to enhance and extend the sexual experience, and to counter the 
effects of other party drugs [1, 13]. While some GBM, particularly those who use EDM 
weekly or more frequently, may do so for specific medical conditions involving erectile 
dysfunction, much of the use in our sample appears to be at least as often for 'recreational' as 
it is for therapeutic purposes. 
Peer influence and social connection appear to be factors associated with the use of EDM by 
GBM. Those who were more socially engaged with other gay men were significantly more 
likely to use EDM. Overall, EDM use appears to be relatively common among GBM, and 
most of those who used EDM also reported having gay friends who also used it, suggesting 
that EDM use is fairly normalized among GBM. Less than one in five GBM who did not use 
EDM themselves reported having friends that used it. Additionally, more sexually active men 
and those who participated in intensive sex partying were particularly likely to report EDM 
use in the previous six months.  
HIV-positive men tend to be older [22], and are more likely to be involved in subcultures 
where intensive sex partying occurs [15, 23], both of which are associated with EDM use. 
Regardless, self-reported HIV-positive status was not independently associated with weekly 
or more frequent EDM use. This suggests that the use of EDM for erectile dysfunction may 
be no more common among HIV-positive GBM than it is among other men, and that they are 
at least as likely to be using EDM recreationally.  
Men who used EDM in the previous six months reported fewer symptoms of anxiety and 
depression than those who did not use EDM. However, those who used EDM weekly or more 
often reported more symptoms of anxiety and depression than those who used less frequently. 
Our data provide no evidence of poor mental health among users of EDM overall, but those 
who use EDM on a more frequent basis may be subject to symptoms of anxiety and 
depression. Our data cannot determine whether these symptoms are related to their use of 
EDM or, possibly, to the reasons for their more frequent use of EDM. Those who used EDM 
more frequently were more likely to cite erectile dysfunction as a reason for their use of 
EDM, and erectile dysfunction has been associated with poor mental health outcomes [24, 
25]. On the other hand, those men who use EDM less frequently appeared less likely to do so 
for therapeutic purposes and they tended to have lower scores on both depression and anxiety 
than either the men who used EDM at least weekly or the men who never used EDM. 
Limitations and strengths 
Participants in this study were broadly similar to other samples of Australian GBM [26, 27]. 
Nonetheless, it was a volunteer, online convenience sample and may not be representative of 
all GBM in Australia. Extrapolating these findings to other contexts may be limited by 
differences between Australia and other locations. Also, this was a cross-sectional analysis of 
baseline data from a cohort study and as such it is not possible to determine any causative or 
temporal relationships in the data.  
The Flux Study is Australia’s first large-scale study specifically looking at drug use among 
GBM among whom prevalence is known to be higher than the general population. It includes 
comprehensive detailed data on history of use, and how and why men use drugs. Our large, 
community-based national sample is geographically dispersed and includes men of all ages 
and both those that are engaged and those not engaged with gay community life. Our online 
methodology potentially reduces social desirability bias in reporting illegal or stigmatised 
behaviours [28-30]. 
Conclusion  
While some GBM use EDM specifically for erectile dysfunction, many also use EDM to 
enhance their sexual experiences. Often, this occurs in the context of intensive sex partying, 
which may include risky sexual behavior. GBM who use EDM also use illicit drugs at higher 
rates compared to those who do not use EDM. The use of EDM in the context of intensive 
sex partying (which include the combined use of EDM and illicit drugs), with the associated 
potential for increased risk of HIV transmission, indicates a need to consider the use of EDM 
among GBM in HIV prevention. Specifically, there is a need for health promotion initiatives 
with men who engage in intensive sex partying to address the potential of EDM to amplify 
the risk of STI, including HIV, transmission. These initiatives need to acknowledge the emic 
value of EDM within particular sexual cultures, its relationship to CLAI and how this may 
conflict with harm minimization approaches.  
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Table 1: Characteristics of sample according to use of erectile dysfunction medication. N=2250 
n (%) Never used 
EDM 
(n=1523) 
Used EDM > 
6 months ago 
(n=249) 
Used EDM < 
monthly in previous 
6 months (n=258) 
Used EDM about 
monthly in previous 
6 months (n=119) 
Used EDM at least 
weekly in previous 6 
months (n=101) 
Age***      
Mean (SD) 29.02 (10.85) 38.76 (10.99) 39.01 (10.96) 45.60 (12.81) 49.51 (12.62) 
20 or less 328 (21.5) 2 (0.8) 4 (1.6)  1 (0.8) 2 (2.0) 
21-30 698 (45.8) 60 (24.1) 61 (23.6) 11 (9.2) 9 (8.9) 
31-40 276 (18.1) 90 (36.1) 87 (33.7) 30 (25.2) 12 (11.9) 
41-50 130 (8.5) 51 (20.5) 63 (24.4) 43 (36.1) 27 (26.7) 
Over 50 91 (6.0) 46 (18.5) 43 (16.7) 34 (28.6) 51 (50.5) 
Cultural background***      
Anglo-celtic 1051 (69.0) 181 (72.7) 201 (77.9) 98 (82.4) 89 (88.1) 
 Other 429 (28.2) 63 (25.3) 53 (20.5) 20 (16.8) 11 (10.9) 
Not stated 43 (2.8) 5 (2.0) 4 (1.6) 1 (0.8) 1 (1.0) 
Education***      
Less than university level 775 (50.9) 97 (39.0) 107 (41.5) 35 (29.4) 49 (48.5) 
Undergraduate level 463 (30.4) 89 (35.7) 87 (33.7) 35 (29.4) 24 (23.8) 
Postgraduate level 282 (18.5) 62 (24.9) 61 (23.6) 49 (41.2) 28 (27.7) 
Not stated 3 (0.2) 1 (0.4) 3 (1.2)  0 (0.0) 0 (0.0) 
Occupation ***      
Managerial 205 (13.5) 49 (19.7) 47 (18.2) 24 (20.2) 24 (23.8) 
Professional 362 (23.8) 90 (36.1) 80 (31.0) 45 (37.8) 26 (25.7) 
Other white collar 240 (15.8) 28 (11.2) 38 (14.7) 11 (9.2) 10 (9.9) 
Other 150 (9.8) 34 (13.7) 31 (12.0) 12 (10.1) 7 (6.9) 
Not in work 566 (37.2) 48 (19.3) 62 (24.0) 27 (22.7) 34 (33.7) 
HIV Status***      
HIV-positive 36 (2.4) 36 (14.5) 52 (20.2) 30 (25.2) 17 (16.8) 
HIV-negative 1057 (69.4) 205 (82.3) 194 (75.2) 87 (73.1) 79 (78.2) 
Unknown/untested 430 (28.2) 8 (3.2) 12 (4.7) 2 (1.7) 5 (5.0) 
In a relationship with regular partner 
Not in a relationship 766 (50.3) 124 (49.8) 120 (46.5) 53  (44.5) 52 (51.5) 
In a relationship 757 (49.7) 125 (50.2) 138 (53.5) 66 (55.5) 49 (48.5) 
Mean (SD) 
Gay social engagement *** 3.16 (1.59) 3.94 (1.54) 4.04 (1.51) 4.53 (1.47) 4.32 (1.70) 
Generalized Anxiety Disorder (GAD-7) 
* 
5.36 (5.27) 4.65 (5.38) 4.59 (4.68) 4.01 (4.60) 4.65 (5.71) 
Patient Health Questionnaire (PHQ-9) 
* 
7.34 (6.20) 6.52 (6.40) 6.33 (5.89)  5.92 (5.75) 6.65 (6.99) 
Sexual sensation-seeking *** 28.2 (6.47) 30.0 (5.84) 31.0 (5.78) 32.8 (5.65) 32.0 (6.44) 
*p<0.05 **p<0.01 ***p<0.001 
  
Table 2: Sexual behaviour and illicit drug use in previous 6 months according to use of erectile dysfunction medication. N=2250 
n (%) Never used 
EDM 
(n=1523) 
Used EDM > 
6 months ago 
(n=249) 
Used EDM < 
monthly in previous 
6 months (n=258) 
Used EDM about 
monthly in previous 
6 months (n=119) 
Used EDM at least 
weekly in previous 6 
months (n=101) 
Number of sexual partners *** 
Mean (SD) 9.21 (32.92) 16.76 (66.87) 21.32 (36.06) 29.59 (43.11) 39.64 (77.00) 
      
No partner 207 (13.6) 24 (9.6) 8 (3.1) 1 (0.8) 2 (2.0) 
Up to 10 979 (64.3) 143 (57.4) 108 (41.9) 60 (50.4) 56 (55.4) 
Over 10 292 (19.2) 74 (29.7) 108 (41.9) 60 (50.4) 56 (55.4) 
Not stated 45 (3.0) 8 (3.2) 8 (3.1) 6 (5.0) 4 (4.0) 
Sex with boyfriends  
No boyfriend 994 (65.3) 149 (59.8) 157 (60.9) 64 (53.8) 64 63.4) 
No anal intercourse 37 (2.4) 6 (2.4) 9 (3.5) 3 (2.5) 3 (3.0) 
Condom use only 65 (4.3) 7 (2.8) 7 (2.7) 7 (5.9) 6 (5.9) 
Any condomless anal intercourse 382 (25.1) 79 (31.7) 77 (29.8) 39 (32.8) 24 (23.8) 
Not stated 45 (3.0) 8 (3.2) 8 (3.1) 6 (5.0) 4 (4.0) 
Sex with fuckbuddy *** 
No fuckbuddies 1040 (68.3) 143 (57.4) 118 (45.7) 44 (37.0) 38 (37.6) 
No anal intercourse 38 (2.5) 8 (3.2) 7 (2.7) 4 (3.4) 3 (3.0) 
Condom use only 167 (11.0) 26 (10.4) 35 (13.6) 11 (9.2) 13 (12.9) 
Any condomless anal intercourse 233 (15.3) 64 (25.7) 90 (34.9) 54 (45.4) 43 (42.6) 
Not stated 45 (3.0) 8 (3.2) 8 (3.1) 6 (5.0) 4 (4.0) 
Sex with casual partners *** 
No casual partners 688 (45.2) 77 (30.9) 41 (15.9) 19 (16.0) 14 (13.9) 
No anal intercourse 83 (5.4) 25 (10.0) 20 (7.8) 14 (11.8) 6 (5.9) 
Condom use only 378 (24.8) 59 (23.7) 73 (28.3) 31 (26.1) 20 (19.8) 
Any condomless anal intercourse 329 (21.6) 80 (32.1) 116 (45.0) 49 (41.2) 57 (56.4)  
Not stated 45 (3.0) 8 (3.2) 8 (3.1) 6 (5.0) 4 (4.0) 
Group sex *** 
No group sex 1124 (73.8) 151 (60.6) 115 (44.6) 49 (41.2) 35 (34.7) 
Any group sex 310 (20.4) 83 (33.3) 129 (50.0) 63 (52.9) 58 (57.4) 
Not stated  89 (5.8) 15 (6.0) 14 (5.4) 7 (5.9) 8 (7.9) 
Recent illicit drug use1      
 *** No recent drug use 345 (22.7) 50 (20.1) 26 (10.1) 9 (7.6) 14 (13.9) 
*** Used amyl nitrite 373 (24.5) 96 (38.6) 139 (53.9) 65 (54.6) 49 (48.5) 
 *** Used cannabis 412 (27.1) 80 (32.1) 100 (38.8) 37 (31.1) 32 (31.7) 
*** Used ecstasy 204 (13.4) 63 (25.3) 77 (29.8) 33 (27.7) 20 (19.8) 
*** Used meth/amphetamine (speed) 69 (4.5) 25 (10.0) 26 (10.1) 7 (5.9) 8 (7.9) 
*** Used cocaine 135 (8.9) 49 (19.7) 57 (22.1) 24 (20.2) 16 (15.8) 
*** Used crystalline methamphetamine  70 (4.6) 44 (17.7) 84 (32.6) 40 (33.6) 31 (30.7) 
*** Used gamma hydroxybutyrate 
(GHB) 
31 (2.0) 21 (8.4) 53 (20.5) 31 (26.1) 20 (19.8) 
*** Ketamine 31 (2.0) 11 (4.4) 18 (7.0) 13 (10.9) 12 (11.9) 
** Lysergic acid diethylamide (LSD) 50 (3.3) 14 (5.6) 11 (4.3) 2 (1.7) 4 (4.0) 
** Heroin 0 (0.0) 1 (0.4) 1 (0.4) 0 (0.0) 1 (1.0) 
Used drugs to enhance sex *** 
Never 1418 (93.1) 192 (77.1) 164 (63.6) 68 (57.1) 63 (62.4) 
Once 39 (2.6) 25 (10.0) 15 (5.8) 9 (7.6) 4 (4.0) 
More than once 66 (4.3) 32 (12.9) 79 (30.6) 42 (35.3) 34 (33.7) 
*p<0.05 **p<0.01 ***p<0.001 
1 Items are not mutually exclusive: Could have used multiple drugs  
  
Table 3: Reasons for use of erectile dysfunction medication in previous six month. N=478 
n (%) Used EDM in the 
previous six months 
n=377 (78.7) 
Used EDM weekly in the 
previous six months 
n=(101) 21.3 
Total (n=478) 
To counter effects of other drugs 153 (40.6) 32 (31.7) 185 (38.7) 
To make condom use easier 77 (20.4) 29 (28.7 106 (22.2) 
To see what it was like *** 64 (17.0) 1 (1.0) 65 (13.6) 
To make it easier to ‘get hard’ * 200 (53.1) 68 (67.3) 268 (6.1) 
Someone else wanted me to use it 23 (6.1) 2 (2.0) 25 (5.2) 
For fun *** 120 (31.8) 10 (9.9) 130 (27.2) 
To maintain erection longer * 230 (61.0) 74 (73.3) 304 (63.6) 
Difficulty attaining or maintaining erection 
*** 
117 (31.0) 54 (53.5) 171 (35.8) 
Needs EDM to take insertive position ** 50 (13.3) 25 (24.8) 75 (15.7) 
*p<0.05 **p<0.01 ***p<0.001 
  
Table 4: Associations with use of erectile dysfunction medication.  
 Any use in the previous six months vs. no use in the 
previous six months. N=2250 
At least weekly use in the previous six months vs. less 
frequent use in the previous six months. n=478 
 Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis 
n (%) OR (CI 
95%) 
p-trends AOR (CI 
95%) 
p-trends OR (CI 
95%) 
p-trends AOR (CI 
95%) 
p-trends 
Age 1.08 (1.07 – 
1.09) 
<0.001 1.08 – 1.06 – 
1.08) 
<0.001 1.06 (1.04 – 
1.08) 
<0.001 1.06 (1.04 – 
1.08) 
<0.001 
Anglo-Celtic 
background 
1.89 (1.47 – 
2.43) 
<0.001   1.94 (1.01 – 
3.71) 
0.047   
University education 1.45 (1.18 – 
1.78) 
<0.001   0.65 (0.42 – 
1.01) 
0.056 0.62 (0.39 – 
0.98) 
0.042 
Relationship with 
regular partner 
1.14 (0.93 – 
1.39) 
0.221   0.80 (0.52 – 
1.24) 
0.317   
HIV-positive 6.17 (4.46 – 
8.52) 
<0.001 2.06 (1.38 – 
3.06) 
<0.001 0.73 (0.41 – 
1.30) 
0.280   
Socially engaged 
with other gay men 
1.46 (1.37 – 
1.57) 
<0.001 1.20 (1.10 – 
1.30) 
<0.001 1.05 (0.91 – 
1.22) 
0.481   
PHQ9 0.98 (0.96 – 
0.99) 
0.006   1.01 – 0.96 – 
1.05) 
0.517   
GAD 0.97 (0.95 – 
0.99) 
0.004   1.01 (0.96 – 
1.06) 
0.668   
Sensation seeking 1.09 (1.07 – <0.001 1.05 (1.03 – <0.001 1.01 – (0.97 0.563   
scale 1.11) 1.08) – 1.05) 
     
Over 10 partners 3.39 (2.74 – 
4.19) 
<0.001   1.55 (0.96 – 
2.41) 
0.053   
Group sex 4.08 (3.28 – 
5.07) 
<0.001 1.59 (1.20 – 
2.120 
0.001 1.42 (0.89 – 
2.26) 
0.146   
Condomless anal 
intercourse with 
fuckbuddies 
3.19 (2.56 – 
3.99) 
<0.001 0.54 (0.40 - 
.071) 
<0.001 0.83 (0.53 – 
1.30) 
0.424   
Condomless anal 
intercourse with 
casual partners 
2.89 (2.34 – 
3.57) 
<0.001   0.60 (0.39 – 
0.94) 
0.024 0.59 (0.37 – 
0.94) 
0.025 
Used drugs to 
enhance sex 
8.20 (6.20 – 
10.84) 
<0.001 5.25 (3.71 – 
7.43) 
<0.001 1.07 (0.67 – 
1.71) 
0.765   
a Used amyl nitrite 3.97 (3.17 – 
4.98) 
<0.001   0.77 (0.47 – 
1.24) 
0.273   
a Used marijuana 1.51 (1.21 – 
1.88) 
<0.001   0.82 (0.50 – 
1.32) 
0.409   
a Used ecstasy 2.29 (1.79 – 
2.92) 
<0.001   0.60 (0.35 – 
1.04) 
0.068   
a Used 
meth/amphetamine 
(speed) 
1.75 (1.19 – 
2.57) 
0.004   0.90 (0.40 – 
2.01) 
0.789   
a Used cocaine 2.33 (1.78 – 
3.07) 
<0.001   0.69 (0.38 – 
1.25) 
0.218   
a Used crystalline 
methamphetamine 
7.64 (5.82 – 
10.04) 
<0.001   0.875 (0.54 
– 1.42) 
0.587   
a Used GHB 9.64 (6.78 – 
13.71) 
<0.001   0.80 (0.47 – 
139) 
0.434   
a Used ketamine 4.26 (2.75 – 
6.60) 
<0.001   1.52 (0.75 – 
3.09) 
0.247   
a Used LSD 1.01 (0.59 – 
1.75) 
0.963   1.15 (0.37 – 
3.60) 
0.814   
a Used heroin 7.42 (0.67 – 
82.03) 
0.102   3.84 (0.24 – 
61.89) 
0.343   
a Omitted from multivariate model due to possible multicollinearity. 
 
 
 
 
 
 
